These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 37881891)
1. Hydroxychloroquine-Chloroquine, QT-Prolongation, and Major Adverse Cardiac Events: A Meta-analysis and Scoping Review. Garcia MC; Tsang K; Lohit S; Deng J; Schneider T; Matos Silva J; Mbuagbaw L; Holbrook A Ann Pharmacother; 2024 Jul; 58(7):742-755. PubMed ID: 37881891 [TBL] [Abstract][Full Text] [Related]
2. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299 [TBL] [Abstract][Full Text] [Related]
3. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine. Sarayani A; Cicali B; Henriksen CH; Brown JD Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397 [TBL] [Abstract][Full Text] [Related]
4. Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase. Saint-Gerons DM; Tabarés-Seisdedos R Eur J Clin Pharmacol; 2021 Oct; 77(10):1513-1521. PubMed ID: 33938974 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports. Goldman A; Bomze D; Dankner R; Hod H; Meirson T; Boursi B; Maor E Br J Clin Pharmacol; 2021 Mar; 87(3):1432-1442. PubMed ID: 32964535 [TBL] [Abstract][Full Text] [Related]
6. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study. Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133 [TBL] [Abstract][Full Text] [Related]
7. QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis. Diaz-Arocutipa C; Brañez-Condorena A; Hernandez AV Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):694-706. PubMed ID: 33772933 [TBL] [Abstract][Full Text] [Related]
8. Proarrhythmic major adverse cardiac events with donepezil: A systematic review with meta-analysis. Nham T; Garcia MC; Tsang KJ; Silva JM; Schneider T; Deng J; Lohit S; Mbuagbaw L; Holbrook A J Am Geriatr Soc; 2024 Aug; 72(8):2552-2565. PubMed ID: 38580328 [TBL] [Abstract][Full Text] [Related]
9. Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions. Souza Botelho M; Bolfi F; Leite RGOF; Leite MSF; Banzato LR; Soares LT; Olivatti TOF; Mangolim AS; Oliveira FRK; Abbade LPF; Abbade JF; de Barros Almeida RAM; Simões Corrêa Galendi J; Thabane L; Dos Santos Nunes-Nogueira V Syst Rev; 2021 Nov; 10(1):294. PubMed ID: 34736537 [TBL] [Abstract][Full Text] [Related]
10. Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing. Shah RR J Clin Pharm Ther; 2021 Feb; 46(1):17-27. PubMed ID: 32981089 [TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine and Chloroquine-Induced Cardiac Arrhythmias and Sudden Cardiac Death in Patients With Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis. Nikolic RPA; Virk MK; Buhler KA; Costenbader KH; Choi MY; Weber BN J Cardiovasc Pharmacol; 2024 Aug; 84(2):158-169. PubMed ID: 38922589 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials. Eze P; Mezue KN; Nduka CU; Obianyo I; Egbuche O Am J Cardiovasc Dis; 2021; 11(1):93-107. PubMed ID: 33815925 [TBL] [Abstract][Full Text] [Related]
13. QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review. Jankelson L; Karam G; Becker ML; Chinitz LA; Tsai MC Heart Rhythm; 2020 Sep; 17(9):1472-1479. PubMed ID: 32438018 [TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
15. American College of Rheumatology White Paper on Antimalarial Cardiac Toxicity. Desmarais J; Rosenbaum JT; Costenbader KH; Ginzler EM; Fett N; Goodman S; O'Dell J; Pineau CA; Schmajuk G; Werth VP; Link MS; Kovacs R Arthritis Rheumatol; 2021 Dec; 73(12):2151-2160. PubMed ID: 34697918 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine. de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793 [TBL] [Abstract][Full Text] [Related]
17. Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis. Oscanoa TJ; Vidal X; Kanters JK; Romero-Ortuno R Int J Antimicrob Agents; 2020 Dec; 56(6):106212. PubMed ID: 33164789 [TBL] [Abstract][Full Text] [Related]
18. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection. Saleh M; Gabriels J; Chang D; Soo Kim B; Mansoor A; Mahmood E; Makker P; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Chinitz J; Skipitaris N; Mountantonakis S; Epstein LM Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008662. PubMed ID: 32347743 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis. Kumar J; Jain S; Meena J; Yadav A J Infect Chemother; 2021 Jun; 27(6):882-889. PubMed ID: 33678548 [TBL] [Abstract][Full Text] [Related]
20. Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis. Liu D; Li X; Zhang Y; Kwong JS; Li L; Zhang Y; Xu C; Li Q; Sun X; Tian H; Li S Drug Des Devel Ther; 2018; 12():1685-1695. PubMed ID: 29928112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]